Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. (DRTS): ~8 mo cash runway · 21 clinical trials. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
8.1 months
D/E 0.37 · 0% dilution
N/A
N/A
N/A
0 buys · 2 sells (180d)
A transparent, data-derived signal for Alpha Tau Medical Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$844.5M
Cash
$12.2M
Quarterly Burn
$26.7M
Runway
8.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
46
Total value held
$15.1M
| Holder | Shares | Value |
|---|---|---|
| aquamarine financial (cayman) ltd | 721,501 | $5.1M |
| ark investment management llc | 292,134 | $2.1M |
| citadel advisors llc | 140,395 | $993K |
| levin capital strategies, l.p. | 106,423 | $752K |
| jane street group, llc | 102,839 | $727K |
| susquehanna international group, llp | 83,438 | $590K |
| geode capital management, llc | 53,399 | $378K |
| wells fargo & company/mn | 49,300 | $349K |
| private advisor group, llc | 47,583 | $336K |
| millennium management llc | 46,445 | $328K |
Showing top 10 of 46 institutional holders of Alpha Tau Medical Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
What is Alpha Tau Medical Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Alpha Tau Medical Ltd. has approximately 8.1 months of cash runway.
What is Alpha Tau Medical Ltd.'s market capitalization?
Alpha Tau Medical Ltd.'s market capitalization is approximately $844.5M.
Who is the CEO of Alpha Tau Medical Ltd.?
Mr. Uzi Sofer is the chief executive officer of Alpha Tau Medical Ltd. (DRTS).
Get the full picture on Alpha Tau Medical Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.